AOFLEX II, LLC has filed a new offering under Rule 506(b) of the Securities Act, which allows for a private offering of securities. This filing, dated November 13, 2026, indicates the company’s intent to raise funds through a private investment vehicle. Such moves are increasingly common in the investment fund sector, as firms look for alternative financing options.
The company is based in Atlanta, Georgia, and operates as a limited liability company. According to its recent filings, AOFLEX II is categorized as a pooled investment fund. The filing does not provide specific details about the investment amounts or terms, but it does indicate that the offering will be indefinite in duration.
Background
AOFLEX II, LLC was established in 2026 and is incorporated in Delaware. The company specializes in pooled investment funds, which are designed to aggregate capital from multiple investors to invest in various assets. The firm’s address is 980 Hammond Drive, Suite 200, Atlanta, GA 30328.
What the Filing Says
The SEC filing states that the offering is being conducted under Rule 506(b), which provides a safe harbor for private offerings. It mentions that the company has not yet commenced sales and that the total offering amount is indefinite. The filing also notes that the company has not accepted any investments yet.
Impact
This filing may affect potential investors looking for opportunities in the private investment fund market. By utilizing Rule 506(b), AOFLEX II, LLC aims to attract accredited investors without the same level of regulatory scrutiny as public offerings. This could position the company favorably among its peers in the investment sector.
What's Next
The filing does not say what happens next. However, the company’s next steps may involve marketing the offering to potential investors and finalizing the terms of the investment.
Read Next
Dominion Energy announces $1.2 billion senior notes issuance
Lakefront Biotherapeutics Launches €50 Million Share Buyback
Coca-Cola Europacific Partners Announces Share Buyback Details
Zenta Group announces $6.47 million at-the-market offering
MapLight Therapeutics Enters $100 Million Sales Agreement
Cyabra, Inc. Secures $15.6 Million in Private Placement










